| Business Summary | | Sulzer
Medica
designs,
manufactures
and
markets
artificial
joints,
spinal
implants,
traumatology
and
arthroscopy
products,
dental
implants,
heart
valves
and
vascular
grafts.
At
December
31,
1999,
the
Company
had
nine
manufacturing
facilities
located
in
North
America,
Switzerland,
France
and
Scotland,
eight
of
which
also
house
research
and
development
activities.
Of
these
facilities,
the
Company
owns
its
primary
manufacturing
facility
for
its
Orthopedics
Division
in
Austin,
Texas,
and
its
manufacturing
facility
in
Inchinnan,
Glasgow,
Scotland.
The
Company
operates
through
two
divisions,
the
Orthopedics
division
and
the
Cardiovascular
Prostheses
division. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | SM
designs,
manufactures
and
markets
artificial
joints,
spinal
implants,
traumatology
and
arthroscopy
products,
dental
implants,
heart
valves
and
vascular
grafts.
For
the
fiscal
year
ended
12/31/00,
revenues
rose
14%
to
SF1.35
billion.
Net
income
under
U.S.
GAAP
fell
74%
to
SF189M.
Results
reflect
strong
growth
in
the
Orthopedics
Division
and
the
Cardiovascular
Prostheses
Division,
offset
by
the
absence
of
a
SF591M
gain
on
sale
of
the
Electrophysiology
Division. | More
from
Market Guide: Significant
Developments |
| Officers | |
| Position | Max Link, 60 | Chairman | Stephan Rietiker, M.D. | Pres,
CEO | Urs Kamber | CFO | Steven Hanson, 46 | Pres,
Sulzer Calcitek Inc. | Rich Lunsford, 42 | Pres,
Sulzer Spine-Tech, Inc. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|